DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Hallez S, Simon P, Maudoux F. et al.
Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia.
Cancer Immunol Immunother 2004; 53: 642-650
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.